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1INTRODUCTION
Pterygium was recognised 3000 yrs ago. It was described by
Susrutha way back in 1000 B.C. in India. Pterygium literally means
“wing” and is an encroachment of the conjunctiva on thecornea, more
often on the nasal side and is found in areas of high ultraviolet radiation,
dry, hot, windy, dusty, and smoky environments1. There are usually no
problems in diagnosing it but treatment can be difficult2. Currently it is
believed that limbal stem cells and pterygial fibroblasts exposed to
ultraviolet rays are damaged3. The indications for surgery include
reduced visual acuity due to encroachment upon the visual axis and
irregular astigmatism and also due to chronic irritation and recurrent
inflammation, and cosmesis4.
The treatment of choice is surgery5 and various techniques exist
with the resulting defect being left exposed or covered by surrounding
conjunctiva or a limbalautograft or other tissues. Adjunctive therapy
with anti-metabolites has been tried6. The use of amniotic membrane
has been used as a viable alternative to conjunctivalautografts.
The need for conducting the present study is to evaluate the
clinical presentation and effective management of primary pterygium
with conjunctivalautograft and amniotic membrane graft.
2REVIEW OF LITERATURE & HISTORY
      The word pterygium comes from the Greek root “pterygios”
which means “little wing”. Susrutha an Indian doctor who lived in 1000
B.C. gave an accurate description of a pterygium and its treatment with
pulverised salt and stimulation with a palm branch and when it was
inflamed and swollen he tore it out with forceps and removed any
remaining tissue with a flesh stripping ointment. He also described its
recurrence10. Hippocrates and many other ancient greats like Celso,
Galeno, Egineta and Avicenna described various approaches to the
treatment of a pterygium12,13.
      Ambrose Pare described it as an abnormality which always
recurs8,9. In the 18th century copper sulphate was used in treatment while
in the 19th century silver nitrate and lead acetate and atropine were used.
Surgery first appeared as a treatment modality in the 19thcentury7,11,14.
Scarpa (1802):  Removal of head from the cornea with a forceps
and concentric excision of the detached tissue as far as the limbus18.
Arlt (1850): Excision of the head from the head from the cornea
and a diamond shaped portion of the body with conjunctival cross-over
plastic surgery19.
3Desmarres (1855): Technique of deviating the head towards
superior fornix and inducing it to atrophy20.
Knapp (1869):Technique of transposition21.
Arlt (1872): First scleral repair following excision of the
pterygium15,22.
McReynolds(1902): Modified Desmarres technique using a
conjunctival pouch16,23.
Gifford(1909): Epidermal growth to cover the sclera24.
Morax and Magitot(1911): Used first artificially preserved
homologous corneal grafts25.
Terson (1911): Radiation therapy with X-Rays26.
Fuchs (1911): Autologous penetrating keratoplasty and Terson
(1913) used this for pterygia17.
Magitot (1916): Suggested lamellar autokeratoplasty27.
Amorin (1936): Suggested use of a diathermy coagulator28,29.
D’Ombrain (1948): Technique of bare sclera32.
Paufique (1950):Developed a lamellar keratoplasty31,33.
Haik (1957): Topical beta therapy with Strontium 9030,34.
4Meacham (1962):Used antimitotics to prevent recurrences35.
Panzardi (1964):Used amniotic membrane for repair of defect36.
Kenyon (1985): Grafting autologous conjunctiva to prevent
recurrences37.
Anatomy of conjunctiva
5ANATOMY OF THE CONJUNCTIVA
      The conjunctiva is a thin translucent mucous membrane which
derives its name from the fact that it joins the eyeballs to the lids38.
      It lines the posterior surface of the lids and then is reflected
forwards on to the globe of the eye. Its epithelium becomes continuous
anteriorly with the epithelium of the cornea39.
      Thus it forms a complex space, the conjunctival sac which is open
in front of the palpebral fissure, and closed only when the eyes are
shut40. It has three regions:
1. Palpebral conjunctiva
2. Bulbar conjunctiva
3. Fornix conjunctiva
      Since pterygium is confined to the bulbar conjunctiva this part is
described in detail.
Structure of conjunctival epithelium
6The Bulbar Conjunctiva:
      It is a thin and translucent mucous membrane. It lies loosely on
the underlying tissues, so that it can be easily moved apart from them.
      It is loosely attached by connective tissue to the sclera and fascia
bulbi. About 3mm from the cornea, the conjunctiva becomes more
closely attached to the sclera and fascia bulbi. At the point of union, the
conjunctiva is sometimes raised by a slight ridge, which becomes
apparent in inflammatory conditions. This portion of conjunctiva is
known as the limbal conjunctiva.
Structure Of Conjunctiva:
      The conjunctiva like all other layers consists of two layers the
epithelium and sub mucosal lamina propria41.
Epithelium:
The epithelium consists of non-keratinised squamous cells
arranged in five layers. The deeper layer consists of high cylindrical
cells. This is followed by several layers of polyhedral cells,the most
superficial cells are flattened. Near the limbus, the layers of squamous
cells are gradually reduced and replaced by columnar and cubical cells.
The total numbers of layers is also reduced41.
Goblet cell distribution
7      The epithelium of the tarsal conjunctiva of the upper eyelid
consists of two layers. From the limbus to the fornix the epithelium
becomes more and more glandular.
At the limbus the epithelium is definitely stratified with the
formation of papillae that give a deep aspect of epithelium a
characteristic wavy outline.Here  the deepest or basal layer forms a
single layer of cylindrical or cubical cells. The basal cells often contain
pigment granules. Goblet cells occur in whole of conjunctiva including
the plica semilunaris. They are large oval or round cells, which look like
flat cells.
The goblet cells in the conjunctiva are greatly increased in
number in inflammatory conditions. Associated with the conjunctiva are
a number of small glands differentiated both histologically and
topographically into different types. These are collectively called as
conjunctival glands and distinguished only by eponymous names- the
glands of Wolfring, the Henle’s gland and the gland of Manz. These
glands secrete mucin41.
The conjunctival sub mucosa has a superficial lymphoid layer
and a deeper fibrous layer. The lymphoid layer is not present at birth,
but is formed first in the region of the fornix at the age of 3 to 4 months.
Blood supply of conjunctiva
8It consists of fine connective tissue reticulum in the meshes of which the
lymphocytes lie. The fibrous layer is generally thicker than the
lymphoid. The vessels and nerves of conjunctiva are present in this
layer.
Conjunctival Papillae:
True papillae are found only at the limbus and at the lid margin.
Those near the limbus are finger like processes of sub mucosal tissue,
the interspaces of which are filled with epithelium while the surface
epithelium remains flat.
Blood Supply:
The arterial supply of the conjunctiva is from three sources:
1. The peripheral arterial arcade of the lid
2. The marginal arcade of the lid
3. The anterior ciliary arteries.
The peripheral arterial arcade is situated at the upper border of
tarsus. It gives off peripheral perforating branches that pass above the
tarsal plate and pierce the palpebral muscle to reach the conjunctiva,
under which it sends branches upwards and downwards.
9      The marginal arcade sends its perforating branches through the
tarsus to reach the deep surface of the conjunctiva at the subtarsal fold.
These branches divide into marginal and tarsal twigs.
The anterior ciliary arteries are the branches of muscular arteries
to the recti. Each muscular artery gives off two anterior ciliaries except
that of  lateral rectus which gives off one branch.
      The anterior ciliary arteries give off the anterior conjunctival
arteries, which pass forwards at a deeper level than posterior
conjunctival vessels. They pass further and anastamose with each other
and form a series of arcades parallel to the corneal margin and forms
peri-corneal plexus. The peri-corneal plexus is arranged in two layers,
superficial conjunctival and deep episcleral plexus42.
Conjunctival Veins:
The conjunctival veins accompany, but are more numerous than
the corresponding arteries. For the most part, tarsal conjunctiva, fornix
and the major portion of the bulbar conjunctiva drain into palpebral
veins.
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Lymphatics:
The conjunctival lymphatics are arranged in two plexuses. A
superficial composed of small vessels, placed just beneath the vascular
capillaries and consisting of larger vessels, situated in the fibrous layer
of the conjunctiva and receiving the lymph from the superficial plexus.
They drain towards the commissures where they join the
lymphatics of the lids ; those from the lateral side are drained by the pre
auricular nodes and those from the medial side are drained by the sub
mandibular nodes.
Nerve Supply:
The circum-corneal zone of conjunctiva is supplied by long
ciliary nerve. The remaining part of the conjunctiva is supplied by the
lacrimal and infra trochlear nerve42.
Anatomy and histology of cornea
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ANATOMY OF THE CORNEA
With the advent of the electron microscope, the following five
layers have been identified.
1. Layers of stratified squamous epithelium
2. Bowman’s membrane – the anterior limiting lamina
3. The substantia propria
4. Descemet’s membrane – the posterior limiting lamina
5. The endothelium
Layer of Stratified Squamous Epithelium:
This layer is approximately 50 milli microns thick and consists of
5 to 6 layers of cells. The deepest of these, the basal cells are columnar.
They are the germinal layer and are continuous at the corneal periphery
with the same layer in the conjunctiva.
The next layer consists of polyhedral cells whose rounded heads
are directed anteriorly and whose concave bases fit over the heads of the
basal cells.
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The next two or three layers are also polyhedral and most
superficial are flattened but do not lose their nuclei, nor do they show
keratinisation. The flattened nuclei of the surface cells project
backwards leaving the surface perfectly smooth, which makes it the
most brilliant in the body43.
Bowman’s membrane:
The anterior limiting lamina is a thin homogenous sheet about 8
to 14 milli microns thick between the basement membrane and the
substantia propria.
The anterior limiting lamina is not truly elastic, nor does it
regenerate when it has been destroyed. It however shows a good deal of
resistance to injury or infection.
Electron Microscopy44: an acellular mass of collagen fibrils is
disposed irregularly.
The SubstantiaPropria:
It is composed of modified connective tissue. It is about 0.5mm
thick. The collagen fibrils are not visible under light microscopy.
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Electron Microscopy44: the fibres are in alternating direction.
They are parallel and in alternate layers they lie at right angles. In man,
the collagen corpuscles line within and not between the collagen
lamellae.
Descemet’s Membrane:
The posterior limiting lamina, a thin elastic membrane covered on
its posterior surface by endothelium. It is a strong and homogenous and
a very resistant membrane. It is 10 to 12 milli microns thick. It is very
resistant to chemical reagents and likewise to pathological processes
going on in the cornea.
Electron Microscopy44: composed of very fine regular strata of
fine collagenous fibres. In man they are disposed in two layers, an outer
‘banded’ against the substantiapropria and inner stroma against the
endothelium.
The Endothelium:
Single layer of flattened hexagonal cells.The endothelium of the
cornea can be seen by slit lamp in the living eyes, the only place in the
body where this is possible.
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In the corneal epithelium there are no glands. Embryologically
the cornea is the continuation of three structures:
a. The epithelium and Bowman’s membrane of the conjunctiva
b. The substantiapropria of the sclera
c. The endothelium of the uveal tract
Pathologically too, this is of importance, for the epithelium is
liable to be affected in diseases of the conjunctiva, the stroma diseases
of the sclera and the posterior lamina and endothelium in diseases of the
uveal tract45.
Pterygium – anatomy
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ANATOMY OF THE PTERYGIUM
Macroscopic:
Pterygium consists of a head, an apex towards the advancing
edge, neck and the body lying limbal to the head.
The Head:
The active part of the pterygium causing changes to the cornea in
front of it, forming the cap and activates the subconjunctival connective
tissue behind it forming the body. It ranges from fibrous, flat and
avascular to the fleshy gelatinous type. The head is always firmly
adherent to the underlying cornea.
The Cap:
This is the apex and slightly transparent with the cornea visible
upto the Descemet’s membrane. It is usually avascular47.
The Neck:
The narrowest part of the pterygium, where the body and apex
join.
The Body:
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It is wing shaped and lies over the sclera. The adherent
conjunctiva is dragged along with it and stretched so folds appear. There
is always some degree of associated subconjunctival connective tissue
hyperplasia47.
The pigment line:
It is seen about a millimetre ahead of the cap. Iron from
lactoferrin in the tears are deposited in the advancing edge of the
pterygium as “Stocker’s line.
Microscopic Structure48:
1. Fibroplastic tissue separating the corneal basement epithelial cells
from the Bowman’s membrane.
2. Altered orientation of the basal epithelial cells overlying the
fibroplastic tissue.
3. Destruction of the Bowman’s and superficial stroma beneath the
fibroplastic tissue.
4. Normal corneal tissue proximal to the leading edge of the
pterygium.
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Characteristic features of Ocular Pterygia49:
a. Hyalinisation of the sub epithelial connective tissue of the
substantiapropria
b. Increased number of thickened and tortuous fibres
c. Connections within the hyalinised and granular areas that
may show either eosinophilia or basophilia.
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DEFINITION AND CLASSIFICATION
The definition of pterygium varies according to the author.
Sir Stewart Duke Elder: true pterygium is a degenerative and
hyperplastic process in which the conjunctiva actively invades the
cornea. It is essentially a triangular encroachment of the bulbar
conjunctiva into the cornea7.
Robert G. Small: A pterygium is a triangular wedge of fibrous
tissue covered by conjunctiva, which grows from the nasal limbus,
slightly below the midline, onto the cornea, beneath the basement
membrane of the corneal epithelium.
True pterygium: It is a degenerative and hyperplastic process in
which the conjunctiva actively invades the cornea48.
Pseudo pterygium: This  is  a  condition  in  which  a  fold  of
inflammed conjunctiva becomes adherent to a progressive ulcer near the
corneal margin and is passively drawn across the cornea.
True pterygium and pseudo pterygium
      True pterygium        Pseudo pterygium
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DIFFERENCE  BETWEEN TRUE AND PSEUDO PTERYGIUM
TRUE PTERYGIUM PSEUDO PTERYGIUM
Probe cannot be passed Probe can be passed
Nasal and temporal aspects Any part
Degenerative and hyperplastic process Inflammatory process
Usually single May be multiple
Recurrences seen No recurrence
HISTORY HISTORY
No h/o injury, chemosis or
inflammation
History present
AGE AGE
After 20-25 yrs Any age
SHAPE SHAPE
Wing shaped No typical shape
GROWTH GROWTH
May progress, regress, be stationaryor
atrophy
Remains stationary
Stoker’s , Bussacca’s lines seen Not seen
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Different authors have classified pterygium in different ways:
WILLIAM M. TOWNSEND CLASSIFICATION50:
A. Actively growing
B. Slow growing
C. Fleshy or malignant
D. Stationary
E. Atrophic
LUCIO BARRATO’S CLINICAL CLASSIFICATION:3 main
clinical types
Type 1: Small primary pterygium51
     These are initial forms of pterygia with very mild or no symptoms.
a. Fibrous :
- Small whitish or yellowish circles parallel to the limbus
- Conjunctival blood vessels converging towards the circles
- The body is not clearly distinguished
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b. Pinguecular:
- Appearance similar to a pinguecula, protruding
- Head can just about be identified and does not invade cornea
- 2-3 mm of stromal infiltration
c. Classical:
- All portions can be clearly identified
- Apex invades 1-2mm of the cornea
Type 2: Advanced Primary or Recurrent pterygium with no
optical Zone involvement51
Irritation and initial reduction in vision occurs due to irregular
astigmatism. The cornea is invaded for 2-4mm and reaches the optical
zone. The body is thickened with dilated, congested capillaries. The
corneal infiltration can be seen with the naked eye.
Type 3: Advanced Primary or Recurrent pterygium with Optical
Zone involvement51:
There are obvious symptoms with serious reduction in vision.
There may be oculo-motory disturbances and a watery eye syndrome.
The head invades the cornea for more than 4mm and reaches the optical
22
zone. There is always a reduction in vision, and the collarette is
extended (up to 8-10mm) and the body extends up to the entire medial
canthus. There is abundant sub-conjunctival fibrosis which extends as
far as the fornices.
GRADING OF PTERYGIUM BASED ON EXTENT52,53:
Based on the amount of corneal encroachment, the pterygium is
graded as follows45:
? Grade I   –  crossing the limbus
? Grade II  – midway between the limbus and pupil
? Grade III – crossing the pupillary margin
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INCIDENCE
Pterygium is a common ophthalmic condition of tropics and sub
tropics. It is a condition found commonly in sunny, hot, windy coastal
regions of the world, mostly between the latitude of 32° north and south
of the equator. The incidence also varies with the amount of exposure to
climactic conditions. It is most common in those who work outdoors
and therefore more among men than women (2:1) except in localities
where the exposure for both are equal. In some communities its
incidence is almost exclusively confined to rural workers and
fishermen42.
Site:
It affects mostly the nasal part of the conjunctiva and occasionally
is present on both sides. It may affect one eye or both eyes. The normal
flow of tears is from the temporal to nasal side towards puncti. It carries
dust particles to the conjunctival sac and accumulates in the lacus
lacrimalis. These concentrated dust particles may cause greater irritation
of nasal conjunctiva.
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Age and Sex Distribution:
It is more among males and increases with age. It affects adults
between 20 and 40 years of age. It is rare among children.
Occupation:
It is most common among people who are exposed to effects of
long standing irritation. Thus it is common among stonecutters and
farmers. Hence people who are exposed to outdoor work, dust, wind,
smoke, heat and bright light are prone to get pterygium26.
Environmental Factors:
This condition is more common in localities where the weather is
to the hot side and the sunlight is brilliant. This explains the frequency
of pterygium among stonecutters and inhabitants of certain localities.
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AETIOLOGY AND HISTOPATHOGENESIS12,32,45
The biological and pathogenic factors that cause pterygia are not
well understood and it is unknown why recurrences occur in some
inspite of receiving the same treatment strategies.
HEREDITARY FACTORS
A pterygium may be hereditary and run in families with a
dominant gene of incomplete penetrance. This refers to a predisposition
of the conjunctiva to an abnormal response to atmospheric or
environmental stimuli.
PINGUECULAR
Suggested by Fuchs and expanded by Guillermo Pico and
others47. According to this theory the primary lesion is a pinguecula.
The microerosions caused at the limbus by environmental or lacrimal
factors, provokes a defence reaction in the conjunctiva. When this lesion
involves the cornea it produces edema which causes the migration of
limbal keratoblasts, the so called “advancement front” of the lesion or
“Fuch’s progressive area”.
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INFLAMMATORY
Arlt, Scarpa, Hirschberg, Von Grafae and Kamel have supported
this theory which states that erosions and micro erosions provoked by
environmental and professional stimuli at the limbus incites sub clinical
inflammation in the conjunctiva25.
ANOMALIES OF TEAR FILM
Discontinuity of the tear film with formation of small dellen and
epithelial micro ulcerations is the initial stimulus and this was
emphasised by Barraquer61.
DIET / NOURISHMENT
      By Beard and Dimitry stating that a deficiency of Choline and
Vitamin A is the cause.
ANGIOGENIC TISSUE FACTORS
      Wong stated that repeated irritation of the limbus produces an
angiogenic factor which gives rise to a pterygium.
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IMMUNE MECHANISM
Suggested by Hilgers56 in the sixties. Due to imbalance in cell
mediated immunity, a prevalence of CD3 lymphocytes with suppressor
activity is present. The ratio between helper and suppressor cells in the
normal conjunctiva is 1:1.5 while in pterygia the mean ratio is 1:2.7. In
addition mast cells, plasma cells and deposits of immunoglobulin with
the characteristic granular pattern may be seen.
ENVIRONMENTAL ULTRAVIOLET RADIATION
This is currently the most credible theory. Kerknezov (1956)
found that an outdoor life was essential for pterygium formation.
Cameron mapped the incidence rates of pterygia and showed the disease
was concentrated in preequatorial regions and increased towards the
equator.
The working hypothesis is that UV rays cause mutations in the
p53 tumour suppressor gene and this facilitates abnormal proliferation
of limbal epithelium54.
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PATHOLOGY
The pathogenesis of pterygia is not fully understood and recent
evidence implicating genetic components, anti-apoptotic components,
cytokines, growth factors, extracellular matrix remodelling,
immunological mechanisms and viral infections in the pathogenesis of
the disease.
Low levels of pigment epithelium derived factor and increased
vascular endothelial growth factor levels have been implicated in the
pathogenesis45.
Pterygium epithelial cells also show a unique feature of positive
immune histochemical staining pattern for different types of matrix
metalloproteinases53. Evidence shows that pterygia originate from
invasion of Vimentine expressing altered limbal epithelial basal cells4.
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DIFFERENTIAL DIAGNOSIS
1. PSEUDOPTERYGIUM  –  situated  anywhere  and  is  due  to  an
inflammatory process.
2. PINGUECULA – seldom encroaches on the cornea except when it
is very large.
3. EPITHELIOMA –it has a more irregular surface, lacks thickened
sub conjunctival connective tissue at the caruncle and there is an
absence of orientation of blood vessel into the characteristic
pterygial shape.
4. BOWEN’S TUMOUR – rare tumour with features similar to
epithelioma.
5. EPITHELIAL HYPERPLASIA – increase in subconjunctival
connective tissue with white or grey plaques surrounded by
erythema mimic a pterygium.
6. SQUAMOUS CELL CARCINOMA OF THE LIMBUS – it is
very rare but hard to differentiate from a pterygium at times. It is
more common in the infero-temporal zone of the limbus. The
definitive diagnosis is by histological examination.
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7. CONJUNCTIVAL  PAPILLOMA  –  it  is  highly  vascular  and
bleeds easily and is of a viral origin.
8. LIMBAL DERMOID – rare congenital pathology seen mostly in
the infero-temporal sector.
9. PHLYCTENULAR KERATOCONJUNCTIVITIS – small
circumscribed conjunctival neo- formation with a gel like
appearance and surrounded by twisted capillaries and associated
with conjunctival hyperemia.
10.LYMPHOMA  OF  THE  CONJUNCTIVA  –  very  rare  and  is  a
salmon pink sub-conjunctival lesion mainly on the inferior and
nasal bulbar conjunctiva.
11.NODULAR EPISCLERITIS – localised nodular forms appear as a
bright red almost flat nodule. It is seen more often in young adult
females.
The differential diagnosis of pterygium should also include
conjunctival intraepithelial neoplasia, squamous cell carcinoma, a
corneal micro pannus etc. The characteristic features of these clinical
entities will help to distinguish them from a pterygium.
Structure of amniotic membrane
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AMNIOTIC MEMBRANE
Amniotic membrane is the innermost semi-transparent layer of
the foetal membranes. It has an avascular stromal matrix, a thick
collagen layer and an overlying basement membrane with a single layer
of cuboidal epithelium. Amniotic membrane, used as a graft initially in
194054, gained popularity in reconstructive surgeries since 1995.
Properties of Amniotic Membrane54:
Courtesy: IJO 2005
Amniotic membrane procurement
32
Preparation55,56:
The following steps may be followed to finally obtain quality AM
for transplantation. The required transport medium, the washing
solutions and preservative medium, properly checked for sterility should
be made available at least a day before the collection and preparation of
the membrane. The working solutions and media should have been
prepared 7 - 10 days ahead with complete verification of pH and
sterility. It is preferable to prepare these solutions when required. The
preparation is described below:
? The detailed medical history and clinical condition of the potential
donor should exclude the risk of tissue-transmissible infections
and unsuitability of the donors.
? Donors are screened for human immunodeficiency virus (HIV)
type 1 and 2, hepatitis B virus (HBV), hepatitis C virus (HCV)
and Treponema pallidum infections.
? The Amniotic Membrane should be obtained under sterile
conditions after elective caesarian section.
? The Amniotic Membrane is dissected from the placenta in two
large bits. As much of the chorion as possible should be peeled out
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before the bits are dropped into a sterile, wide mouthed 125 ml
screw-capped reagent bottle containing 50 ml transport medium.
The transport medium generally used is the commercially
available Eagles' minimum essential medium (EMEM)
supplemented with 3.3% L-glutamine and antibiotics (50 ?g/ml
gentamicin, 100 units/ml penicillin, 200 ?g/ml ciprofloxacin and 1
mg/ml Amphotericin B). The membrane must be transported
immediately to the laboratory.
? In the laboratory, under the laminar flow hood, the Amniotic
Membrane is washed free of blood clots with EMEM containing
antibiotics.
? With the epithelial / basement layer surface up, the Amniotic
Membrane is spread uniformly without folds or tears on
individually sterilised 0.22 ?m nitrocellulose membranes of the
required size.
? The Amniotic Membrane with the filter membrane is placed
carefully in the preservative medium in 50-ml wide mouthed
screw-capped irradiated transparent plastic bottles. The
preservative medium used is 1:1 (vol/vol) ratio of sterile glycerol
(sterilized by autoclave) and EMEM with 3.3% L-glutamine, 25
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?g/ml gentamicin, 50 units / ml penicillin, 100 ?g/ml
ciprofloxacin and 0.5 mg/ ml Amphotericin B.
? Thedevitalization of the epithelial cells of the Amniotic
Membranes is done by storing at -80°C.
? The membrane is thawed by keeping the bottle either at 4°C for 30
minutes or at room temperature for 10 minutes.
? Microbial contamination should be avoided and the storage
medium should be light pink on thawing as opposed to yellow
which indicates contamination.
? Before usage, the epithelial side can be identified by its stickiness
to a cotton swab.
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FIBRIN GLUE
Suturing is a time consuming process and may cause redness and
irritation. Hence nowadays it is being increasingly replaced by tissue
adhesives like Fibrin Glue, a blood derived product which is absorbable
and easy to use. It acts as a smooth seal along the wound edges and it
can be stored at room temperature. It is obtained as a commercially
available preparation and may be prepared in blood banks58.
Components
1. Fibrinogen component
2. Thrombin component
Mechanism of action
Final common pathway
     XIII
        Thrombin XIIIa
Fibrinogen   Fibrin Fibrin Fibrin Clot
       (monomer)             (polymer)             (Insoluble)
Ca 2+
Fibrin glue
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Method of preparation
A precipitate having fibrinogen and a thrombin containing
supernatant is obtained after centrifugation.
Commercially available fibrin is:
Tisseell VH Fibrin Sealant (Baxter, AG, Vienna, Austria) – FDA
Approved
Preparation:
For its preparation the cold chain has to be maintained. Color
coded vials are first warmed in a patented fibrotherm device. Then the
fibrinolysis inhibitor (aprotinin) is added to the sealer protein
concentrate and a second component is prepared by injecting calcium
chloride vial into thrombin vial and warmed. Only a small amount of
thrombin – calcium chloride complex is needed to drive the reaction.
Then 0.1 ml of thrombin calcium chloride solution is diluted with
0.9 ml of balanced salt solution to achieve 1:10 dilution. A syringe is
then placed into the duploject injector along with a parallel syringe
containing fibrin sealer protein and fibrinolysis inhibitor. A mixer
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nosecone topped by blunt applicator needle is attached to the 2-syringe
nozzle. Then the common plunger is depressed causing fibrin sealer
solution and thrombin solution to mix in equal volume.
A dry surgical field is required for application and the tissue must
be left undisturbed for three minutes for firm adhesion.
Techniques of Application:
1. Simultaneous Application
2. Sequential Application
Advantages:
1. It reduces the total surgical time
2. Lower risk of post-operative infection
3. Mixtures of fibrin glue and antibiotic – helps in local delivery of
antimicrobial activity
4. Smooth seal along entire length of wound with higher tensile
strength
5. Useful adjunct to control bleeding
6. Low incidents of allergic reactions
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MANAGEMENT
   Is usually conservative, unless the following situations arise7,21,25,27:
? Decrease in vision due to mixed astigmatism or growth extending
on to the visual axis.
? Cosmesis.
? Foreign body sensation and irritation not responding to medical
treatment.
? Limitation of extra ocular movements due to restriction.
? Progression of growth towards the visual axis suggesting that
visual loss will ultimately occur.
Pterygium induced astigmatism can lead to visual disturbances. It
is usually with-the-rule astigmatism. It produces tear film abnormalities
and it also exerts a mechanical pull on the cornea. But it is incorrect to
label the entire astigmatism as “induced” as many may have a natural
component too58.
With increase in size, the induced astigmatism also
proportionately increases. A pterygium larger than 3mm to 3.5mm
(more than halfway to the centre of the pupil) are likely to be associated
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with > 1 D of astigmatism 59. The improvement in vision after surgery
may be due to two causes:
a. Reduction in astigmatism, and
b. Removal of pterygium from the visual axis.
MEDICAL APPROACH
General recommendations for the prevention of pterygia should
include the avoidance of exposure to ultra violet radiation.
Studies have shown that the development of pterygium is strongly
associated with exposure to UV rays in the first five years of life and
hence parents should be advised to protect their children from UV ray
exposure, especially if the residence is within 30° of the equator.
The use of ultraviolet absorbing protective spectacles, sunglasses
and hats is advisable.
Mild irritative symptoms due to pterygium may be managed with
topical lubricants or a mild topical vasoconstrictor. A mild topical
corticosteroid (eg.Fluorometholone  0.1% QID ) may be useful for
moderate to severe vascular injection and irritative symptomatology.
40
Secondary dellen may be managed with preservative free
lubricating ointments and temporary patching for 24 hours 21,25.
SURGICAL APPROACHES
Ideally a pterygium surgery should have low or no recurrence,
with minimal complications and be cosmetically acceptable. No single
approach has been found to be perfect and each has its own advantages
and disadvantages. All procedures regardless of adjunctive measures
employed begin with the surgical removal of the pterygium from the
globe. Dissection is either done from the body to the head or vice versa.
The various approaches are:
EVULSIONS
     A horse hair or flax thread or even squint hooks and corrugated silver
wires have been used for dissecting the pterygial head from the
underlying corneal tissue.
TRANSPLANTATION OF THE HEAD
     Various techniques redirect the head of the pterygium away from the
cornea to prevent recurrences. They consisted of burying the head
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underneath the normal conjunctival edge inferiorly. But with recurrence
rates of 30-75 % they have been largely abandoned20,35.
PTERYGIUM EXCISION / AVULSION
      Avulsing a thin, relatively transparent, primary pterygium by
mechanically shearing off the head from the underlying cornea has been
tried. It has the advantage of resulting in a smooth corneal surface, rapid
epithelialisation and minimal scarring. But many pterygia cannot be
avulsed and have to be excised59. Deep lamellar keratectomies offer no
distinct advantages.
STEPS OF PTERYGIUM EXCISION
      A reliable method described by Kenyon et al. consisted of the
following steps.Peribulbar anaesthesia and a lid block are usually used
but for a simple excision, topical Lignocaine and a sub-conjunctival
injection of Lignocaine may suffice.
A rigid lid speculum is used. Limbal stay sutures are placed at 12
o’clock and 6 o’clock positions. The head is dissected away from the
cornea by tenting the pterygium apex with the fine forceps and then
performing a delineating keratotomy at the leading edge with a rounded
sharp blade to obtain a superficial plane of dissection. The remainder of
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the pterygium head is carefully dissected from the superficial cornea in
a lamellar fashion up to the limbus with a Tooke’s knife. Excision of the
bulbar conjunctival extent of the pterygium is carried out up to the
limbus using blunt dissection with Westcott’s scissors. The pterygium is
then excised from the remaining limbal attachment with scissors. All
involved conjunctiva, underlying Tenon’s capsule and scar tissue are
ultimately removed down to bare sclera60.
Care must be taken to avoid damage to the underlying rectus
muscle, which can be enmeshed in the fibrovascular tissue (especially in
recurrent cases). Wet field cautery is used to cauterize the bleeding
vessels as necessary.The exposed bulbar conjunctiva margins are then
tacked down to the sclera with several 10.0 nylon sutures (some
advocate 8.0 vicryl sutures) with attention not to recess or advance the
margins excessively. At this point the surgeon can proceed with
conjunctival auto grafting for either primary or recurrent pterygium40.
BARE SCLERA TECHNIQUE
Here the resultant scleral and corneal defects would be left to
epithelialize post-operatively (d’Ombrian 1948). It was theorised that a
pterygium recurrence would be prevented if the corneal epithelium
could heal before the conjunctival epithelium reached the
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limbus49,50.Unfortunately Youngson reported a recurrence rate of 37%52.
And Ehlers reported upto 91% recurrence in combination with excimer
laser corneal ablation to smooth the corneal surface61.
CONJUNCTIVAL FLAPS AND CONJUNCTIVAL AUTOGRAFTS
Healthy conjunctival tissue when approximated to the limbus
following excision of a pterygium is associated with a low recurrence
rate. Three basic variations on this theme exist:
Pterygium excision with Primary Conjunctival Closure
Primary conjunctival closure is achieved by undermining adjacent
normal superior and inferior bulbar conjunctiva and pulling the cut
conjunctival edges together to achieve primary conjunctival closure.
Patient aged less than 40 yrs and those with aggressive pterygium
activity are risk factors for recurrences19,27.
Pterygium Excision With Rotational Flap
Rotational conjunctival flaps to cover the pterygium excision site
have been employed since the 1940s. Aratoon in  1967  reported  a
recurrence rate of less than 1% in a series of 150 consecutive procedures
by using a conjunctival pedicle flap after pterygium resection62. A report
by Wilson and Bourne discussed a re-directional conjunctival flap
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technique originally known as a Z-plasty63, the procedure involved
rotating a flap of normal conjunctiva into a limbal position while
simultaneously rotating the remaining pterygium body laterally onto the
bulbar conjunctiva after resecting the head from the cornea. Two
advantages of this procedure include the preservation of normal
conjunctiva for possible future free grafting and normal conjunctival
tissue next to the limbus acts as a barrier to prevent recurrence.
Pterygium Excision With Conjunctival Autograft
Kenyon et al described conjunctival free graft transplant as a
treatment for pterygium in 1985. This technique utilises a free
conjunctival graft from the superotemporal bulbar conjunctiva to cover
the exposed scleral surface after pterygium excision. A 5.3% recurrence
rate was reported. The authors recommend this treatment modality for
advanced primary and recurrent pterygium, especially when concurrent
fornix reconstruction is required or when conjunctival scarring involves
the extra ocular muscles. The importance of including limbal tissue in
the conjunctivalautograft, to reduce the recurrence rate, has been
described by Rao SK et al. This method decreases the chances of scleral
necrosis seen with other adjunctive therapies 40.
Surgical steps for conjunctival autografting
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Procedure for conjunctival autograft surgery:
      After the excision of the pterygium, the size of the scleral defect
created is measured with Castroviejo callipers. The dimensions of the
intended conjunctival graft are marked with gentian violet marking
pen.The gentian violet marks aid not only in the excision of an
approximately sized donor graft but also are invaluable in preventing
inadvertent upside down orientation of the graft in the recipient bed.
 Balanced salt solution is then injected sub-conjunctivally outside
of the gentian violet marks to elevate the conjunctiva to aid in the
conjunctival dissection. Blunt Westcott’s scissors are used to incise the
posterior border of the graft. The conjunctiva is then undermined using
blunt dissection with care taken to not include the underlying Tenon’s
capsule in the final graft. The lateral edges of the donor graft are incised
outside of the gentian violet marks as the dissection is carried forward.
The donor conjunctival graft should be as thin as possible so that post-
operative healing will occur with less shrinkage. It is also important that
the limbal conjunctiva is incised last after the entire graft has been
dissected forwards to the limbus. This assures that the graft will not
retract and become difficult to handle. Handling of the donor
Graft fixation with fibrin glue
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conjunctival tissue only occurs with non-toothed forceps (eg.McGregor
conjunctival forceps),so as to avoid a buttonhole in the conjunctiva.
      At this point, the graft is oriented with the unmarked limbal donor
edge adjacent to the limbus in the recipient bed and the gentian violet
marks on the exposed surface of the conjunctiva. The graft is secured
with 10.0 nylon(buried knots) to avoid a post- operative graft
dehiscence. Graft fixation can also be achieved with fibrin glue62.
      The majority of these sutures usually extrude by their own within
one month of the surgery, while the rest epithelialize and remain buried.
Patient discomfort is usually not a problem due to the usage of
permanent sutures. The occasional exposed stitch can be removed after
adequate conjunctival healing in the early post-operative period.
The donor harvest site is left to epithelialize on its own, which
usually occurs in the first several post-operative days. Post-operative
steroid and antibiotic drops six times a day during the first 1 or 2 weeks
and switch to a steroid drop alone after that time. Lubricating drops may
be used 4-6 times per day for 4-6 weeks.
      The main drawback of the conjunctival free graft technique is the
increased surgical time required, compared to other bare sclera or
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primary closure techniques. Additionally an operating microscope is
required for optimum results. Disadvantages are outweighed by the lack
of sight-threatening complications and the relatively low recurrence
rates after conjunctival free grafts63.
Complications Of Pterygium surgery:
      These are infrequent and not generally sight threatening7,16,21.
Intra-operative
? Haemorrhage
? Injury to the medial rectus muscle
? Loss of orientation
? Donor site haemorrhage
? Button holing of the graft
? Dipping of the graft
Post-operative
? Conjunctival graft edema
? Corneoscleral dellen
? Epithelial inclusion cysts
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? Tenon’s granuloma – usually in the first 2 weeks. It is often
associated with recurrence and should be excised.
? Subconjunctival fibrosis at harvest site causing EOM restriction
and diplopia
? Graft retraction
? Giant papillary conjunctivitis due to suture irritation
? Symblepharon formation more with inferior donor sites
Lamellar keratoplasty and penetrating keratoplasty
If significant corneal thinning is present as a consequence of
previous pterygium surgery, lamellar keratoplasty may be indicated to
restore the normal ocular surface integrity. Lamellar keratoplasty acts as
a barrier to pterygium regrowth. In severe cases where the visual axis is
affected by thinning and scarring, penetrating keratoplasty may be
indicated to visually rehabilitate the eye64.
Mucous membrane grafts and skin grafts
Other grafting substances include buccal mucous membrane, skin
taken from the flexorsurface of the forearm, behind the ear or from
redundant skin of the upper lid. In cases in which sufficient conjunctiva
Amniotic membrane – intra operative
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is not available for a pedicle graft, Trivedi et al recommended the use of
a mucous membrane graft from the lower lip after pterygium excision62.
The clinical circumstance of generalised conjunctival disease
preventing rotational flaps or free grafts is uncommon. A split thickness
skin graft decreases the incidence of recurrences in cases of secondary
recurrent pterygia and presents an acceptable “white” eye post-
operatively. The cosmetic appearance of skin grafting does not approach
the excellent results of conjunctival rotational flaps or autografts48.
Based on the paucity of reports, using skin grafts, the technique has not
received widespread acceptance.
AMNIOTIC MEMBRANE GRAFT PROCEDURE
After the excision of the pterygium, the defect is then closed with
human processed amniotic membrane. Amniotic membrane of required
size is taken and then placed over the bare sclera with the basement
membrane side up. The amniotic membrane is sutured to the episcleral
tissue at the edge of the bare sclera border with 10-0 nylon sutures.
Amniotic membrane fixation could also be achieved with fibrin glue.
The patients were prescribed Prednisolone acetate eye drops that were
tapered off 1 month following surgery along with lubricants for 4 wks.
Antibiotics were given in the immediate postoperative period for 2wks.
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ADJUNCTIVE THERAPY
In an effort to lower the recurrence rates after pterygium excision,
several adjunctive treatment modalities have been developed.
The following are recommended for both advanced primary and
recurrent pterygium.
THIOTEPA
It  is  a  nitrogen  mustard  analogue  in  use  since  1962.  It  is  an
alkylating agent that interferes with normal mitosis and cell division in
all rapidly proliferating tissues65.
Common recommended form is to mix 15mg Thiotepa in 30ml of
Ringer’s solution for a final dilution of 1:2000 strength. The medication
is used topically every 3 hours during the day starting 2 days post-
operatively for a total of 6-8 weeks time.
Complications include early and late onset poliosis and periorbital
skin depigmentation that can become permanent, a major reason for it
not gaining widespread acceptance.
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MITOMYCIN C:
It acts by undergoing reduction activation and then it interacts
with DNA to form monofunctional adducts as well as covalent
crosslinks.
The use of topical Mitomycin C eye drops of 0.2-0.4 mg/ml
strength 2-4 times daily was advocated to prevent pterygium recurrence.
Alternatively Mitomycin C can also be applied to the bare sclera
left behind after pterygium excision. 0.25 mg/ml of MitomycinC is
applied to the bare sclera directly for 1-3 minutes. Recurrence rates with
0.2-0.4 mg/ml Mitomycin was in the range of 5-9% 63,59.
Complications mainly include scleral ulceration, necrotizing
scleritis, scleral calcifications, infections, severe secondary glaucoma
etc.
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RECURRENCE
The perfect result of a pterygium excision would be a normal
appearance of the conjunctiva. The initial stages usually consist of a few
blood vessels growing in a triangular fashion 44. This proceeds to
definite recurrence where the blood vessels are accompanied by a
variable amount of subconjunctival tissue. Sometimes a few blood
vessels reach 1-2 mm onto the cornea (Gibson’s vascularized scar).
“Any fibrovascular growth extending across the limbus onto the
cornea at the site of surgical excision is defined as a recurrence”. This
may be more distressing to the patient than the primary one. The onset
of recurrence was recorded as the date on which the recurrence was
noted irrespective of the duration between that visit and the previous
visit36. Majority of recurrences can be detected within the first 1 month
period and almost all invariably by 6 months.
The risk factors for recurrence include geographic location, age
and morphology of the pterygium. It has been noted that males, age < 40
years and those with vascular pterygia have higher recurrence rates.
Bare sclera technique and primary closure have high recurrence rates
and therefore should be avoided.
PART - II
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AIM
To compare the efficacy and safety of amniotic membrane graft
as a viable alternative to conjunctival autograft in pterygium surgery.
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MATERIALS AND METHODS
70 Patients(70 eyes)  presenting to the outpatient department of
Stanley Medical Hospital, Chennai with Pterygium were included in this
study.
Patients were randomly selected and divided into two groups of
35 each. One group underwent pterygium excision and replacement with
conjuctival autograft using fibrin thrombin glue and the other group
pterygium excision and replacement with amniotic membrane graft
using fibrin thrombin glue.
Amniotic membrane was obtained from RSRM hospital and then
processed and stored as per the guidelines.
The importance of surgical excision and the surgical procedure
was explained to the patient following which informed consent was
obtained.
Routine Pre operative evaluation done as per standards
1. Relevant ocular history.
2. Uncorrected and best corrected visual  acuity
3. Slit lamp examination of type and extent of pterygium
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4. Pre operative refraction
5. Fundus examination
SURGICAL STEPS
? Peribulbar anaesthesia was given
? Head of pterygium was separated from the corneal surface.
After excision of the head and most of the body of
pterygium, sub-conjunctival tissue was dissected and
excised.
? Size of defect was measured and appropriate size
conjunctival autograft was taken from superotemporal
quadrant of the same eye and graft fixation was achieved
using fibrin glue.
? For the amniotic membrane group, appropriate size
amniotic membrane graft was used and placed with the
basement side facing upwards. Graft fixation was achieved
using fibrin glue.
Post operative
Conjunctival autogrft
Amniotic membrane graft
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? Post operatively patient was prescribed antibiotic –steroid
eye drops 6 times a day which was gradually tapered over 4
weeks.
POST OPERATIVE ASSESSMENT
Post operatively, patients were assessed on day 1, 1week, 1 month
and 6months. Assessment included ocular symptoms, slit lamp
examination of graft position and complications, refraction and
recurrence.
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INCLUSION CRITERIA
1. Patients above 20 years of age
2. Primary pterygium invading >2mm of cornea.
EXCLUSION CRITERIA
1. Eyelid disorders
2. Recurrent Pterygium
3. Pseudo pterygium
4. Anterior segment disorders
5. Prior history of ocular surgeries
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OBSERVATIONS
Table – 1 Patient distribution
Number of Patients Count %
Conjuntival Autograft Group 35 50.00
Amniotic Membrane Graft Group 35 50.00
Figure – 1aBar diagram showing patient distribution
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Figure – 1b Pie diagram showing patient distribution
The chart shows that 50% of the patients were in the Conjunctival
Autograft  group ( n = 35) and the remaining 50% belonged to the
Amniotic membrane group.
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Table – 2 Age and sex distribution
Age (Years) Male % Female % Total %
21-30 4 5.71 9 12.86 13 18.57
31-40 13 18.57 10 14.29 23 32.86
41-50 11 15.71 14 20.00 25 35.71
51-60 4 5.71 5 7.14 9 12.86
Total 32 45.71 38 54.29 70 100.00
Figure – 2a Bar diagram showing age and sex distribution
From the above data it is seen that the incidence of pterygium is
highest in the third (32.86%) and fourth decades (35.71%) of life in both
males and females.
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Figure – 2b Pie chart showing age distribution in male patients
Figure – 2c Pie chart showing age distribution in female patients
The maximum occurrence of pterygium among the male patients
was in the 31-40 yrs age group. Among the females the occurrence of
pterygium was maximum in the 41-50 age group.
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Table – 3 Gender distribution
Male % Female %
Conjuntival Autograft Group 13 18.57 22 31.43
Amniotic Membrane Graft Group 19 27.14 16 22.86
Total 32 45.71 38 54.29
The table shows that 45.71% of the affected patients were males
and 54.29% of the affected patients were females in the entire study
group.
Figure – 3a Bar diagram showing gender distribution in each group
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Figure – 3b Pie chart showing gender distribution in the
conjunctival autograft group
Figure – 3c Pie chart showing gender distribution in the amniotic
membrane group
In the ConjunctivalAutograft group 37% were males and 63%
were females. In the Amniotic membrane group 54% were male and
46% were female.
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Table – 4 Occurrence of pterygium with respect to occupation
Occupation
No. of
Patients %
Farmer 12 17.14
Carpenter 3 4.29
Coolie 8 11.43
Watchman 6 8.57
Cook / Maid 10 14.29
Housewife 16 22.86
Vendor 15 21.43
Figure – 4a Bar diagram showing occurrence of pterygium with
respect to occupation
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Figure – 4b Pie chart showing occurrence of pterygium with respect
to occupation
In the entire study, pterygium was most prevalent in the outdoor
occupation group with 62.85% of the affected  patients belonging to this
group.  Among those working outdoors the most affected were farmers
and vendors.  The remaining 37.14% of the patients worked indoors.
66
Table – 5 Laterality of pterygium
Latrality
No. of
Patients %
Unilateral RE 25 35.71
LE 22 31.43
Bilateral BE 23 32.86
From the above table it is seen that among the study group, 47
patients had unilateral pterygium, while 23 patients had bilateral
pterygium.
Figure – 5a Bar graph showing laterality of pterygium
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Figure – 5b Pie chart showing laterality of pterygium
From the above chart, pterygium affected 36%, 31% and 33% of
the cases in the right eye, left eye and both eyes respectively.
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Table – 6 Location of pterygium
Location
No. of
Patients %
Nasal 67 95.71
Temporal 3 4.29
Both 0 0
Figure – 6a Bar diagram showing location of pterygium
Out of the 70 patients included in the study, 67 patients (95.71%)
had nasal pterygium, and 3 patients(4.29%) had temporal pterygium.
Incidence of double headed pterygium was 0%
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Figure – 6a Pie chart showing location of pterygium
Incidence of nasal pterygium was much higher than that of
temporal pterygium.
Graft edema
Following conjunctival autograft
Post operative infection
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             COMPLICATIONS- EARLY POST OPERATIVE
Table – 7 Complications observed in the two study groups
Complications CAG AMG
Count % Count %
Graft Edema 5 7.14 2 2.86
Graft Edge Recession 3 4.29 2 2.86
Graft Loss 1 1.43 2 2.86
Infection 0 0.00 1 1.43
Figure – 7a Bar diagram showing complications observed in the
conjunctival autograft and amniotic membrane group
The above data shows that, Graft edema was observed in 5
patients in the conjunctival autograft group and 2 patients in the
amniotic membrane group, in the immediate post operative period. P
value - 0.231(no significant difference)
Graft edge recession
Conjunctival autograft
Amniotic membrane graft
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Graft edge recession was noticed in 3patients and 2 patients in the
conjunctival autograft and amniotic membrane group respectively. P
value – 0.643(no significant difference)
Total loss of graft tissue occurred in 1 patient in the conjunctival
autograft group and 2 patients in the amniotic membrane group. P value
- 0.555(no significant difference)
Post operative infection occurred only in 1 patient who belonged
to the amniotic membrane group. P value - 0.314(no significant
difference)
Recurrence
Conjunctival autograft
Amniotic membrane graft
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COMPLICATIONS- LATE POST OPERATIVE
Table – 8 Recurrence in the two study groups
Procedure
No. of
Patients
No. of
Recurences %
Conjuntival Autograft Group 35 2 5.7143
Amniotic Membrane Graft Group 35 4 11.43
Recurrence of pterygium was seen among 2 patients in the
conjunctival autograft group and among 4 patients in the amniotic
membrane group.?2  =0.729 and P value = 0.393(> 0.05). There was no
significant difference in the recurrence rates of the two study groups.
Figure – 8a Bar diagram showing recurrence of pterygium in
conjunctival autograft and amniotic membrane group
Recurrence rate in the conjunctival autograft group and amniotic
membrane group was 5.71% and 11.43% respectively
73
DISCUSSION
      In India, pterygium is a common problem encountered by
ophthalmologists in their day to day practice. Though surgery is the
treatment of choice, it is associated with a high recurrence rate. Several
surgical techniques evolved over the years, indicating the difficulty in
finding one ‘ideal’ procedure.
      Autologous conjunctival grafting is a simple and effective
procedure and it does not involve loss of tissue. The low recurrence rate
is attributed to the fact that normal conjunctiva acts as a barrier,
preventing proliferation and advancement of the abnormal tissue
towards the limbus. Inspite of the reduction in recurrences,one of the
major concerns has been that it may affect the outcome of
glaucoma-filtration surgery if required in the donor at a later date.In
cases with double headed pterygium or extensive pterygium, this
procedure may not be possible due to the dearth of healthy tissue for
grafting.
      Hence the need for a viable alternative arose and amniotic
membrane was found to be a good option in this regard.
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      Amniotic membrane reduces recurrences by promoting
conjunctival epithelialisation, inhibiting inflammation and suppressing
sub conjunctival fibrosis. Hence, the relevance of a study comparing
these two techniques.
 Pterygium is more common in adults in the middle age group. In
the present study, most of the patients were found to be in the age group
of 41-50 years (35.71%). The next highest affected group was the 31-40
years age group (32.86%). The high incidence seen among these age
groups may be attributed to occupational exposure.
Pterygium is more common in men than women probably due to
greater exposure to dust and environmental factors. But if the
individuals are involved in the same kind of occupation, this sex
difference disappears as reported by J.H. Hillgers56. In the present study,
out of 70 patients, 32 (45.71%) were males and 38 (54.29%) were
females.
     Occupation plays a major role in the aetiopathogenesis of pterygium.
In the present study, pterygium was more common in persons engaged
in outdoor occupations eg. farmers, coolies, vendors and they account
for upto 44 out of  the total 70 cases (62.85%). This is in accordance
with the findings of MacReynolds66, who stated that pterygium is more
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common among farmers than those people employed in sedentary
occupations. Similar studies have been published by Hillgers56,
Anderson and Kerknezov67.
      In the present study, 47 (67.14%) patients had unilateral
pterygium of which right eye was affected in 25(35.71%) and left eye in
22(31.43%) of the patients. Bilateral pterygium was seen in 23(32.86%)
of the patients.
      In the present study 67(95.71%) of the patients had pterygium on
the nasal aspect and 3(4.29%) on the temporal aspect. The nasal aspect
of pterygium has been attributed to the fact that tears carrying dust
particles flow from the temporal to the nasal aspect and accumulate thus
causing greater irritation. This is in accordance with studies done by
Shaw et al.
      In the present study, graft edema was observed in 5(7.14%) and
2(2.86%) patients in the conjunctival autograft group and amniotic
membrane group respectively. This subsided within one week with
topical antibiotics and topical steroids.
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      Graft edge recession was noticed in 3(4.29%) patients in the
conjunctival autogarft group and 2(2.86%) patients in the amniotic
membrane group.
      Loss of graft tissue occurred in 1 patient in the conjunctival
autograft group and 2 patients in the amniotic membrane group.
       Post operative infection did not occur in the conjunctival
autograft group, whereas in the amniotic membrane group 1 patient
developed post operative infection involving the cornea. Fungal
pathogens were isolated. She received topical, systemic anti fungal
medications and was referred to a higher centre where she underwent
therapeutic keratoplasty.
      In the present study, recurrence rate in the conjunctival autograft
group was 5.71% and in the amniotic membrane group was 11.43%.
These rates were similar to those obtained in other studies done by
Kenyon12,  Solomon  et  al68 and Prabhasawat et al43.  In  a  study  by
Memarzadeh F, Fahd AK, Shamie N and Chuck RS, amniotic
membrane transplantation was done in 23 eyes and conjunctival
autografting was done in 40 eyes69. The pterygium recurrence rates after
AM graft and conjunctival autograft were 35 and 25%, respectively.
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CONCLUSION
?  Pterygium is more commonly seen in the third (32.86%) and
fourth (35.71%) decades of life in both males and females.
?  Pterygium was more common among females (54.29%).
?  Incidence of pterygium was found to be more in those engaged
in outdoor occupations ie.62.85% of the total.
?  Unilateral pterygium(67.14% ) was more common than
bilateral pterygium( 32.86%).
?  Nasal pterygium had almost 96% occurrence.
?  Graft edema was seen more in the conjunctival autograft group
(7.14%) than the amniotic membrane group (2.86%).
?  Graft edge recession was seen more among the conjunctival
autograft group (4.29 %).
?  Loss of graft tissue was observed to be greater in the amniotic
membrane group (2.86%).
?  One patient developed post operative infection in the amniotic
membrane group.
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?  Recurrence rate in the conjunctival autograft group was
5.71%.
?  Recurrence rate in the amniotic membrane group was 11.43%.
?  Recurrence rates between the two groups did not show any
statistical significance (p = 0.393).
       Autologous conjunctival grafting is a safe and simple procedure
which is also associated with a low recurrence rate. It also has a lower
incidence of complications. The disadvantage with conjunctival
autografts include the need to use an operating microscope and the need
for considerable surgical skill. This technique is of limited use in cases
with double headed pterygium and in those cases with cicatrical
disorders involving large areas of the conjunctiva. There is an associated
risk that this procedure may affect the outcome of glaucoma filtration
surgery if required in the future.
      Amniotic membrane usage has shown encouraging results
especially in clinical situations requiring extensive tissue repair,
recurrent cases with scarring and in patients who need filtration surgery.
It is also free of rejection. The major drawback however, is that its
procurement under aseptic and sterile conditions is time consuming,
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tedious and requires experience, expertise and financial resources.
Storage and preparation of media requires trained personnel and good
laboratory facilities.
      Thus from the results of our study, I conclude that both amniotic
membrane graft and conjunctival autograft methods are equally
effective treatment options for pterygium surgery, with comparable
recurrence rates and cosmetic results and either may be selected based
on the patient characteristics and the facilities available to the
ophthalmologist.
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Farmer-1 Watchman-4 Vendor-7
Carpender-2 Cook/Maid-5
Coolie  -3 House Wife-6
